0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracellular Vesicle Therapy Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-25T18619
Home | Market Reports | Science| Biological Sciences
Global Extracellular Vesicle Therapy Market Research Report 2024
BUY CHAPTERS

Global Extracellular Vesicle Therapy Market Research Report 2026

Code: QYRE-Auto-25T18619
Report
2026-01-22
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Extracellular Vesicle Therapy Market Size

The global Extracellular Vesicle Therapy market was valued at US$ 988 million in 2025 and is anticipated to reach US$ 1958 million by 2032, at a CAGR of 10.4% from 2026 to 2032.

Extracellular Vesicle Therapy Market

Extracellular Vesicle Therapy Market

Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.
The North American market for Extracellular Vesicle Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Extracellular Vesicle Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Extracellular Vesicle Therapy in Cancer Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Extracellular Vesicle Therapy include FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Extracellular Vesicle Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracellular Vesicle Therapy. The Extracellular Vesicle Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracellular Vesicle Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracellular Vesicle Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Extracellular Vesicle Therapy Market Report

Report Metric Details
Report Name Extracellular Vesicle Therapy Market
Accounted market size in 2025 US$ 988 million
Forecasted market size in 2032 US$ 1958 million
CAGR 10.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Exosome-based
  • Microvesicle-based
Segment by Application
  • Cancer Treatment
  • Regenerative Medicine
  • Drug Delivery
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, SHIFTBIO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Extracellular Vesicle Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Extracellular Vesicle Therapy Market growing?

Ans: The Extracellular Vesicle Therapy Market witnessing a CAGR of 10.4% during the forecast period 2026-2032.

What is the Extracellular Vesicle Therapy Market size in 2032?

Ans: The Extracellular Vesicle Therapy Market size in 2032 will be US$ 1958 million.

Who are the main players in the Extracellular Vesicle Therapy Market report?

Ans: The main players in the Extracellular Vesicle Therapy Market are FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, SHIFTBIO

What are the Application segmentation covered in the Extracellular Vesicle Therapy Market report?

Ans: The Applications covered in the Extracellular Vesicle Therapy Market report are Cancer Treatment, Regenerative Medicine, Drug Delivery, Other

What are the Type segmentation covered in the Extracellular Vesicle Therapy Market report?

Ans: The Types covered in the Extracellular Vesicle Therapy Market report are Exosome-based, Microvesicle-based

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicle Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Exosome-based
1.2.3 Microvesicle-based
1.3 Market by Application
1.3.1 Global Extracellular Vesicle Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer Treatment
1.3.3 Regenerative Medicine
1.3.4 Drug Delivery
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicle Therapy Market Perspective (2021–2032)
2.2 Global Extracellular Vesicle Therapy Growth Trends by Region
2.2.1 Global Extracellular Vesicle Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Extracellular Vesicle Therapy Historic Market Size by Region (2021–2026)
2.2.3 Extracellular Vesicle Therapy Forecasted Market Size by Region (2027–2032)
2.3 Extracellular Vesicle Therapy Market Dynamics
2.3.1 Extracellular Vesicle Therapy Industry Trends
2.3.2 Extracellular Vesicle Therapy Market Drivers
2.3.3 Extracellular Vesicle Therapy Market Challenges
2.3.4 Extracellular Vesicle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicle Therapy Players by Revenue
3.1.1 Global Top Extracellular Vesicle Therapy Players by Revenue (2021–2026)
3.1.2 Global Extracellular Vesicle Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Extracellular Vesicle Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicle Therapy Revenue
3.4 Global Extracellular Vesicle Therapy Market Concentration Ratio
3.4.1 Global Extracellular Vesicle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicle Therapy Revenue in 2025
3.5 Global Key Players of Extracellular Vesicle Therapy Head Offices and Areas Served
3.6 Global Key Players of Extracellular Vesicle Therapy, Products and Applications
3.7 Global Key Players of Extracellular Vesicle Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Extracellular Vesicle Therapy Breakdown Data by Type
4.1 Global Extracellular Vesicle Therapy Historic Market Size by Type (2021–2026)
4.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Type (2027–2032)
5 Extracellular Vesicle Therapy Breakdown Data by Application
5.1 Global Extracellular Vesicle Therapy Historic Market Size by Application (2021–2026)
5.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Extracellular Vesicle Therapy Market Size (2021–2032)
6.2 North America Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Extracellular Vesicle Therapy Market Size by Country (2021–2026)
6.4 North America Extracellular Vesicle Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicle Therapy Market Size (2021–2032)
7.2 Europe Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Extracellular Vesicle Therapy Market Size by Country (2021–2026)
7.4 Europe Extracellular Vesicle Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicle Therapy Market Size (2021–2032)
8.2 Asia-Pacific Extracellular Vesicle Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Extracellular Vesicle Therapy Market Size (2021–2032)
9.2 Latin America Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Extracellular Vesicle Therapy Market Size by Country (2021–2026)
9.4 Latin America Extracellular Vesicle Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicle Therapy Market Size (2021–2032)
10.2 Middle East & Africa Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Diosynth Biotechnologies
11.1.1 FUJIFILM Diosynth Biotechnologies Company Details
11.1.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.1.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.2 EV Therapeutics
11.2.1 EV Therapeutics Company Details
11.2.2 EV Therapeutics Business Overview
11.2.3 EV Therapeutics Extracellular Vesicle Therapy Introduction
11.2.4 EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.2.5 EV Therapeutics Recent Development
11.3 Cellular Biomedicine Group
11.3.1 Cellular Biomedicine Group Company Details
11.3.2 Cellular Biomedicine Group Business Overview
11.3.3 Cellular Biomedicine Group Extracellular Vesicle Therapy Introduction
11.3.4 Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.3.5 Cellular Biomedicine Group Recent Development
11.4 Codiak BioSciences
11.4.1 Codiak BioSciences Company Details
11.4.2 Codiak BioSciences Business Overview
11.4.3 Codiak BioSciences Extracellular Vesicle Therapy Introduction
11.4.4 Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.4.5 Codiak BioSciences Recent Development
11.5 Coya Therapeutics
11.5.1 Coya Therapeutics Company Details
11.5.2 Coya Therapeutics Business Overview
11.5.3 Coya Therapeutics Extracellular Vesicle Therapy Introduction
11.5.4 Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.5.5 Coya Therapeutics Recent Development
11.6 Curexsys
11.6.1 Curexsys Company Details
11.6.2 Curexsys Business Overview
11.6.3 Curexsys Extracellular Vesicle Therapy Introduction
11.6.4 Curexsys Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.6.5 Curexsys Recent Development
11.7 Evox Therapeutics
11.7.1 Evox Therapeutics Company Details
11.7.2 Evox Therapeutics Business Overview
11.7.3 Evox Therapeutics Extracellular Vesicle Therapy Introduction
11.7.4 Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.7.5 Evox Therapeutics Recent Development
11.8 ExoCoBio
11.8.1 ExoCoBio Company Details
11.8.2 ExoCoBio Business Overview
11.8.3 ExoCoBio Extracellular Vesicle Therapy Introduction
11.8.4 ExoCoBio Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.8.5 ExoCoBio Recent Development
11.9 ILIAS Biologics
11.9.1 ILIAS Biologics Company Details
11.9.2 ILIAS Biologics Business Overview
11.9.3 ILIAS Biologics Extracellular Vesicle Therapy Introduction
11.9.4 ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.9.5 ILIAS Biologics Recent Development
11.10 Rion
11.10.1 Rion Company Details
11.10.2 Rion Business Overview
11.10.3 Rion Extracellular Vesicle Therapy Introduction
11.10.4 Rion Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.10.5 Rion Recent Development
11.11 SHIFTBIO
11.11.1 SHIFTBIO Company Details
11.11.2 SHIFTBIO Business Overview
11.11.3 SHIFTBIO Extracellular Vesicle Therapy Introduction
11.11.4 SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.11.5 SHIFTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Extracellular Vesicle Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Exosome-based
 Table 3. Key Players of Microvesicle-based
 Table 4. Global Extracellular Vesicle Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Extracellular Vesicle Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Extracellular Vesicle Therapy Market Share by Region (2021–2026)
 Table 8. Global Extracellular Vesicle Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Extracellular Vesicle Therapy Market Share by Region (2027–2032)
 Table 10. Extracellular Vesicle Therapy Market Trends
 Table 11. Extracellular Vesicle Therapy Market Drivers
 Table 12. Extracellular Vesicle Therapy Market Challenges
 Table 13. Extracellular Vesicle Therapy Market Restraints
 Table 14. Global Extracellular Vesicle Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Extracellular Vesicle Therapy Market Share by Players (2021–2026)
 Table 16. Global Top Extracellular Vesicle Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Extracellular Vesicle Therapy Revenue, 2025
 Table 17. Ranking of Global Top Extracellular Vesicle Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Extracellular Vesicle Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Extracellular Vesicle Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Extracellular Vesicle Therapy, Products and Applications
 Table 21. Global Key Players of Extracellular Vesicle Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Extracellular Vesicle Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global Extracellular Vesicle Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global Extracellular Vesicle Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global Extracellular Vesicle Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Extracellular Vesicle Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. FUJIFILM Diosynth Biotechnologies Company Details
 Table 47. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 48. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Product
 Table 49. FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 50. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 51. EV Therapeutics Company Details
 Table 52. EV Therapeutics Business Overview
 Table 53. EV Therapeutics Extracellular Vesicle Therapy Product
 Table 54. EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 55. EV Therapeutics Recent Development
 Table 56. Cellular Biomedicine Group Company Details
 Table 57. Cellular Biomedicine Group Business Overview
 Table 58. Cellular Biomedicine Group Extracellular Vesicle Therapy Product
 Table 59. Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 60. Cellular Biomedicine Group Recent Development
 Table 61. Codiak BioSciences Company Details
 Table 62. Codiak BioSciences Business Overview
 Table 63. Codiak BioSciences Extracellular Vesicle Therapy Product
 Table 64. Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 65. Codiak BioSciences Recent Development
 Table 66. Coya Therapeutics Company Details
 Table 67. Coya Therapeutics Business Overview
 Table 68. Coya Therapeutics Extracellular Vesicle Therapy Product
 Table 69. Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 70. Coya Therapeutics Recent Development
 Table 71. Curexsys Company Details
 Table 72. Curexsys Business Overview
 Table 73. Curexsys Extracellular Vesicle Therapy Product
 Table 74. Curexsys Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 75. Curexsys Recent Development
 Table 76. Evox Therapeutics Company Details
 Table 77. Evox Therapeutics Business Overview
 Table 78. Evox Therapeutics Extracellular Vesicle Therapy Product
 Table 79. Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 80. Evox Therapeutics Recent Development
 Table 81. ExoCoBio Company Details
 Table 82. ExoCoBio Business Overview
 Table 83. ExoCoBio Extracellular Vesicle Therapy Product
 Table 84. ExoCoBio Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 85. ExoCoBio Recent Development
 Table 86. ILIAS Biologics Company Details
 Table 87. ILIAS Biologics Business Overview
 Table 88. ILIAS Biologics Extracellular Vesicle Therapy Product
 Table 89. ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 90. ILIAS Biologics Recent Development
 Table 91. Rion Company Details
 Table 92. Rion Business Overview
 Table 93. Rion Extracellular Vesicle Therapy Product
 Table 94. Rion Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 95. Rion Recent Development
 Table 96. SHIFTBIO Company Details
 Table 97. SHIFTBIO Business Overview
 Table 98. SHIFTBIO Extracellular Vesicle Therapy Product
 Table 99. SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
 Table 100. SHIFTBIO Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Extracellular Vesicle Therapy Picture
 Figure 2. Global Extracellular Vesicle Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Extracellular Vesicle Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Exosome-based Features
 Figure 5. Microvesicle-based Features
 Figure 6. Global Extracellular Vesicle Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Extracellular Vesicle Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Cancer Treatment Case Studies
 Figure 9. Regenerative Medicine Case Studies
 Figure 10. Drug Delivery Case Studies
 Figure 11. Other Case Studies
 Figure 12. Extracellular Vesicle Therapy Report Years Considered
 Figure 13. Global Extracellular Vesicle Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Extracellular Vesicle Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Extracellular Vesicle Therapy Market Share by Region: 2025 vs 2032
 Figure 16. Global Extracellular Vesicle Therapy Market Share by Players in 2025
 Figure 17. Global Extracellular Vesicle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Extracellular Vesicle Therapy Revenue in 2025
 Figure 19. North America Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Extracellular Vesicle Therapy Market Share by Country (2021–2032)
 Figure 21. United States Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Extracellular Vesicle Therapy Market Share by Country (2021–2032)
 Figure 25. Germany Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Extracellular Vesicle Therapy Market Share by Region (2021–2032)
 Figure 33. China Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Extracellular Vesicle Therapy Market Share by Country (2021–2032)
 Figure 41. Mexico Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Extracellular Vesicle Therapy Market Share by Country (2021–2032)
 Figure 45. Israel Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 49. EV Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 50. Cellular Biomedicine Group Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 51. Codiak BioSciences Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 52. Coya Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 53. Curexsys Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 54. Evox Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 55. ExoCoBio Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 56. ILIAS Biologics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 57. Rion Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 58. SHIFTBIO Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension